Rutgers The State University

Rutgers, The State University of New Jersey, Camden Division operates as a federal grant recipient conducting basic and applied biomedical research, educational workforce development, and community health programs funded by science and health agencies. The division is a tax-exempt non-profit institution and a child of the broader Rutgers, The State University system, competing entirely on a full-and-open basis without set-aside designations.

Rutgers-Camden's federal footprint centers on research grants from the National Science Foundation (NSF) and the National Institutes of Health (NIH), with secondary involvement from the Department of Education and specialty agencies. The institution holds 210 total federal awards across prime and sub roles, with 77 percent prime awards and 23 percent subcontractor awards. Recent activity shows consistent grant volume at roughly 18–22 awards per year in 2022–2024, tapering to 8 in 2025 and 4 new awards by mid-2026. The combined obligated dollar value across all awards stands at $74 million against a combined potential value of $541 thousand, reflecting that most awards carry small grant magnitudes typical of research institutions.

Customer concentration is broad and agency-driven. The top five funding sources account for 50 percent of award count and include the National Science Foundation (48 awards), NSF's Division of Environmental Biology (19 awards), the National Endowment for the Arts (14 awards), the Department of Agriculture's Food and Nutrition Service (13 awards), and NIH's National Institute of General Medical Sciences (10 awards). The Navy's Naval Education and Training Command holds three awards with $519 thousand combined potential value, anchoring the institution's military-tied activity.

Representative prime grant work demonstrates a life sciences and STEM education research profile. Rutgers-Camden received a $199,876 NSF Engineering Research Initiation grant (CFDA 47.041) awarded July 1, 2026, for modeling calcium superionic conductors for solid-state batteries through data-driven screening and atomic-scale simulation, with student research involvement and STEM outreach components. An NIH National Institute of Mental Health award of $558,051 (CFDA 93.242) from May 1, 2026 through April 30, 2029 investigates stress-induced noradrenergic neurotransmission and inflammatory mechanisms in the hippocampus, with emphasis on sex-dependent differences and prazosin as a therapeutic intervention target. NIH's National Institute of General Medical Sciences awarded $423,734 (CFDA 93.859) effective February 12, 2026 through December 31, 2030 to develop in vivo genetic platforms exploring co-evolution of cell-signaling proteins using Drosophila melanogaster, examining Gurken and EGFR interactions. NSF's Division of Molecular and Cellular Biosciences provided $949,958 (CFDA 47.074) for research on inorganic polyphosphate regulation of mammalian mitochondrial physiology, with paid research opportunities for undergraduate students from underresourced communities.

Secondary research themes include computational biology and pandemic preparedness. Rutgers-Camden holds a $151,870 NIGMS award (CFDA 93.859) effective September 1, 2025 through August 31, 2029 for developing computational software tools to identify non-canonical junctions in the SARS-CoV-2 transcriptome and generate hypotheses for novel therapeutic targets and vaccines, with open-source release to the scientific community. A $791,029 NSF grant (CFDA 47.074) awarded September 1, 2025 supports collaborative research on ceramide phosphoglycerate synthesis in gram-negative bacteria, training high school, undergraduate, and graduate students across genetics, biochemistry, and structural biology.

The institution operates sub-awards across a collaborative network anchored by research universities. Rutgers-Camden serves as a subrecipient on a multisite clinical trial for alcohol use disorder treatment led by Indiana University, with local clinical oversight at Rutgers' Ambulatory Care Center. The institution participates in an NSF Dimensions US-South Africa collaborative project led by Washington University, performing phylogenomic inference and managing genomic data for 100 anole species and dwarf chameleon assemblies across multiple sub-award years. A University of Pennsylvania-led grant on protein co-evolution pairs Rutgers-Camden with materials characterization and high school outreach in Camden, New Jersey.

Educational and workforce development grants reflect the Camden campus's community engagement mission. The Department of Education's Office of Postsecondary Education funded a $1.404 million FIPSE grant (CFDA 84.116) for the Rutgers University-Camden Community Partnership Centers (RUC-CPC) initiative supporting postsecondary instruction and research from June 1, 2023 through May 31, 2026. The same agency awarded $272,364 (CFDA 84.042) for TRIO Student Support Services from September 1, 2025 through August 31, 2026. NSF funded a $2 million research traineeship program (CFDA 47.076) titled "Codes for Life" (April 1, 2022–March 31, 2027) training 30 master's and 25 PhD students in biomolecular biology, artificial intelligence, and professional software development to address the communication gap between genomics and proteomics research. An NSF CyberTraining grant from August 1, 2024 supports developing AI4SECURECI curriculum modules in cloud infrastructure cybersecurity for roughly 500 diverse participants.

The sub-award footprint spans health and community development work. Rutgers-Camden receives funding through New Jersey Department of Human Services, Department of State, and Department of Agriculture as a sub-recipient on state-administered federal programs including AmeriCorps initiatives focused on K–12 tutoring in Camden and community health workforce capacity. The National Institute of General Medical Sciences backs a U-RISE program (awarded April 1, 2024 through March 31, 2029) recruiting and training underrepresented STEM students for PhD and MD/PhD pathways.

Ten awards face completion within the next twenty-four months, creating recompete activity concentrated in NSF and NIH renewal cycles. The institution does not hold parent contract vehicles or operate as a prime contractor; all awards are grant-funded or carried on research collaboration sub-agreements. The Naval Education and Training Command IDC N0024409G0059 shows minimal task-order activity (two orders, $19 thousand potential value) and represents an outlier from the research-grant dominant profile.